Skip to main content
Erschienen in: Techniques in Coloproctology 1/2015

01.01.2015 | Original Article

Long-term evaluation of bulking agents for the treatment of fecal incontinence: clinical outcomes and ultrasound evidence

Erschienen in: Techniques in Coloproctology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The injection of bulking agents into the anal canal has been reported to help patients with fecal incontinence. Although it has been advocated as a safe and effective option, substantial data concerning long-term efficacy are still lacking, and the resorption process of the implants has not yet been carefully studied. The aim of our study was to investigate the long-term outcomes of bulking agents for the treatment of fecal incontinence and the behavior of implanted materials in the anorectum.

Methods

At a median follow-up of 7 years, 19 patients with idiopathic fecal incontinence who had received bulking agent implants were evaluated. Clinical, manometric and ultrasound assessments were carried out.

Results

The clinical improvements that were achieved in the short term were not maintained over time. For each patient, the number of implants that could no longer be identified on ultrasound was significantly correlated with poorer clinical long-term outcomes. On average, only 14 % of the originally injected volume was still detectable.

Conclusions

In the long term, perianally injected bulking agents seem to lose effectiveness. The ultrasound assessment suggests that the process of resorption is almost complete, and the implants are no longer effective in treating incontinence.
Literatur
1.
Zurück zum Zitat Shafik A (1993) Polytetrafluoroethylene injection for the treatment of partial fecal incontinence. Int Surg 78:159–161PubMed Shafik A (1993) Polytetrafluoroethylene injection for the treatment of partial fecal incontinence. Int Surg 78:159–161PubMed
2.
Zurück zum Zitat Altomare DF, La Torre F, Rinaldi M, Binda G, Pescatori M (2008) Carbon-coated microbeads anal injection in outpatient treatment of minor fecal incontinence. Dis Colon Rectum 5:432–435CrossRef Altomare DF, La Torre F, Rinaldi M, Binda G, Pescatori M (2008) Carbon-coated microbeads anal injection in outpatient treatment of minor fecal incontinence. Dis Colon Rectum 5:432–435CrossRef
3.
Zurück zum Zitat Guerra F, Velluti F, Crocetti D, La Torre F (2010) PTQTM bulking agent injection for the treatment of fecal incontinence: QoL and manometric evaluation. Pelviperineology 29:27–29 Guerra F, Velluti F, Crocetti D, La Torre F (2010) PTQTM bulking agent injection for the treatment of fecal incontinence: QoL and manometric evaluation. Pelviperineology 29:27–29
4.
Zurück zum Zitat Dodi G, Jongen J, de la Portilla F, Raval M, Altomare DF, Lehur PA (2010) An open-label, noncomparative, multicenter study to evaluate efficacy and safety of NASHA/Dx gel as a bulking agent for the treatment of fecal incontinence. Gastroenterol Res Pract 2010:467136. doi:10.1155/2010/467136 Dodi G, Jongen J, de la Portilla F, Raval M, Altomare DF, Lehur PA (2010) An open-label, noncomparative, multicenter study to evaluate efficacy and safety of NASHA/Dx gel as a bulking agent for the treatment of fecal incontinence. Gastroenterol Res Pract 2010:467136. doi:10.​1155/​2010/​467136
5.
Zurück zum Zitat Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M (2011) Efficacy of dextranomer in stabilized hyaluronic acid for treatment of faecal incontinence: a randomized, sham-controlled trial. Lancet 377:997–1003PubMedCrossRef Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M (2011) Efficacy of dextranomer in stabilized hyaluronic acid for treatment of faecal incontinence: a randomized, sham-controlled trial. Lancet 377:997–1003PubMedCrossRef
6.
Zurück zum Zitat La Torre F, de la Portilla F (2013) Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/Dx) for treatment of faecal incontinence. Colorectal Dis 15:569–574PubMedCrossRef La Torre F, de la Portilla F (2013) Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/Dx) for treatment of faecal incontinence. Colorectal Dis 15:569–574PubMedCrossRef
7.
Zurück zum Zitat Hussain ZI, Lim M, Stojkovic SG (2011) Systematic review of perianal implants in the treatment of fecal incontinence. Br J Surg 98:1526–1536PubMedCrossRef Hussain ZI, Lim M, Stojkovic SG (2011) Systematic review of perianal implants in the treatment of fecal incontinence. Br J Surg 98:1526–1536PubMedCrossRef
8.
Zurück zum Zitat Jorge JM, Wexner SD (1993) Etiology and management of faecal incontinence. Dis Colon Rectum 36:77–97PubMedCrossRef Jorge JM, Wexner SD (1993) Etiology and management of faecal incontinence. Dis Colon Rectum 36:77–97PubMedCrossRef
10.
Zurück zum Zitat Gorton E, Stanton S, Monga A, Wiskind AK, Lentz GM, Bland DR (1999) Periurethral collagen injection: a long-term follow-up study. BJU Int 84:966–971PubMedCrossRef Gorton E, Stanton S, Monga A, Wiskind AK, Lentz GM, Bland DR (1999) Periurethral collagen injection: a long-term follow-up study. BJU Int 84:966–971PubMedCrossRef
11.
Zurück zum Zitat Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD, Lightner DJ (2004) Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup. J Urol 171:1152–1155PubMedCrossRef Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD, Lightner DJ (2004) Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup. J Urol 171:1152–1155PubMedCrossRef
12.
Zurück zum Zitat Maeda Y, Laurberg S, Norton C (2010) Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev 12:CD007959 Maeda Y, Laurberg S, Norton C (2010) Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev 12:CD007959
13.
Zurück zum Zitat Luo C, Samaranayake CB, Plank LD, Bisset IP (2010) Systematic review on the efficacy and safety of injectable bulking agents for passive faecal incontinence. Colorectal Dis 12:296–303PubMedCrossRef Luo C, Samaranayake CB, Plank LD, Bisset IP (2010) Systematic review on the efficacy and safety of injectable bulking agents for passive faecal incontinence. Colorectal Dis 12:296–303PubMedCrossRef
14.
Zurück zum Zitat Watson NFS, Kochy A, Sagar PM (2012) Anal bulking agents for faecal incontinence. Colorectal Dis 14(suppl 3):29–33PubMedCrossRef Watson NFS, Kochy A, Sagar PM (2012) Anal bulking agents for faecal incontinence. Colorectal Dis 14(suppl 3):29–33PubMedCrossRef
15.
Zurück zum Zitat Maeda Y, Vaizey CJ, Kamm MA (2007) Long-term results of perianal silicone injection for faecal incontinence. Colorectal Dis 9:357–361PubMedCrossRef Maeda Y, Vaizey CJ, Kamm MA (2007) Long-term results of perianal silicone injection for faecal incontinence. Colorectal Dis 9:357–361PubMedCrossRef
16.
Zurück zum Zitat Bartlett L, Ho YH (2009) PTQ™ anal implants for the treatment of faecal incontinence. Br J Surg 96:1468–1475PubMedCrossRef Bartlett L, Ho YH (2009) PTQ™ anal implants for the treatment of faecal incontinence. Br J Surg 96:1468–1475PubMedCrossRef
17.
Zurück zum Zitat Tjandra JJ, Chan MK, Yeh HC (2009) Injectable silicone biomaterial (PTQ) is more effective than carbon-coated beads (Durasphere) in treating passive faecal incontinence—a randomized trial. Colorectal Dis 11:382–389PubMedCrossRef Tjandra JJ, Chan MK, Yeh HC (2009) Injectable silicone biomaterial (PTQ) is more effective than carbon-coated beads (Durasphere) in treating passive faecal incontinence—a randomized trial. Colorectal Dis 11:382–389PubMedCrossRef
18.
Zurück zum Zitat Tjandra JJ, Lim JF, Hiscock R, Rajendra P (2004) Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective. Dis Colon Rectum 47:2138–2146PubMedCrossRef Tjandra JJ, Lim JF, Hiscock R, Rajendra P (2004) Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective. Dis Colon Rectum 47:2138–2146PubMedCrossRef
Metadaten
Titel
Long-term evaluation of bulking agents for the treatment of fecal incontinence: clinical outcomes and ultrasound evidence
Publikationsdatum
01.01.2015
Erschienen in
Techniques in Coloproctology / Ausgabe 1/2015
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-014-1236-7

Weitere Artikel der Ausgabe 1/2015

Techniques in Coloproctology 1/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.